Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Doxorubicin Inhibits the Production of Nitric Oxide by Colorectal Cancer Cells

  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Doxorubicin (DOX) is an active and broad spectrum chemotherapeutic agent. Increased inducible nitric oxide synthase (NOS) expression and/or activity have been reported in several human tumors. While the relationship between DOX treatment and the enzymatic activity of endothelial NOS has been well characterized, little is known about the effects of DOX on the expression of iNOS in human cancer cells. In the present study, we characterized the effects of DOX on the nitric oxide (NO) production by colorectal cancer cells, DLD-1. IFN-${\gamma}$/IL-1$\beta$ (CM) increased the production of NO, whereas pretreatment of DOX inhibited the production of NO in response to CM in a dose dependent manner. The increased expressions of iNOS mRNA and protein by CM were completely blocked by DOX without affecting the iNOS mRNA stability. However, DOX activated nuclear factor-kB (NF-kB) in response to CM. Furthermore, the expression of inhibitor kB$\alpha$ was reduced by DOX in a dose dependent manner. Collectively, DOX inhibited the production of NO by DLD-1 cells, which is not linked to well known transcription factor, NF-kB. Therefore, further studies on the possible mechanisms of inhibitory effects of NO production by DOX would be worth pursuing.

Keywords

References

  1. Ambs, S., Hussain, S.P. and Harris, C.C., Interactive effects of nitric oxide and the p53 tumor suppressor gene in car-cinogenesis and tumor progression. FASEB J., 11, 443-448 (1997)
  2. Ambs, S., Merriam, W.G., Bennett, W.P, Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P.G., Billiar, T.R. and Harris, C.C., Frequent nitric oxide synthase-2 expression in human colorectal adenomas: Implication for tumor angiogenesis and colorectal cancer progression. Cancer Res., 58, 334-341 (1998)
  3. Bian, X., McAllister-Lucas, L.M., Shao, E, Schumacher, K.R., Feng, Z., Porter, A.G., Castle, V.P. and Opipari, A.W.J., NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J. Biol. Chem., 276, 48921-48929 (2001) https://doi.org/10.1074/jbc.M108674200
  4. Brune, B., von Knethen, A and Sandau, K.B., Nitric oxide and its role in apoptosis. Eur. J. Pharmacol., 351, 261-272 (1998) https://doi.org/10.1016/S0014-2999(98)00274-X
  5. Chu, S.C., Marks-Konczalik, J., Wu, H., Banks, T.C. and Moss, J., Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun., 248, 871-878 (1998) https://doi.org/10.1006/bbrc.1998.9062
  6. Cobbs, C.S., Brenman, J.E., Aldape, K.D., Bredt, D.S. and Israel, M.A., Expression of nitric oxide synthase activity in human central nervous system tumors. Cancer Res., 55, 727-730 (1995)
  7. Das, K.C. and White, C.W, Activation of NF-$\kappa$B by antineo-plastic agents. J. Biol. Chem., 272, 14914-14920 (1997) https://doi.org/10.1074/jbc.272.23.14914
  8. Denizot, F. and Lang, R., Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods, 89, 271-277 (1986) https://doi.org/10.1016/0022-1759(86)90368-6
  9. Dupraz, P., Cottet, S., Hamburger, F., Dolci, W, Felley-Bosco, E. and Thorens, B., Dominant negative MyD88 proteins inhibit interleukin-1$\beta$/interferon-$\gamma$-mediated induction of nuclear factor $\kappa$B-dependent nitrite production and apoptosis in b cells. J. Biol. Chem., 275, 37672-37678 (2000) https://doi.org/10.1074/jbc.M005150200
  10. Foo, S. and Nolan, G., NF-$\kappa$B to the rescue. Trends Genet., 15, 229-235 (1999) https://doi.org/10.1016/S0168-9525(99)01719-9
  11. Fukumura, D. and Jain, R.K., Role of nitric oxide in angio-genesis and microcirculation in tumors. Cancer Metastasis Rev., 17, 77-89 (1998) https://doi.org/10.1023/A:1005908805527
  12. Green, L., Wagner, D.A, Glogowski, J., Skipper, P.I., Wishnok, J.S. and Tannenbaum, S.R., Analysis of nitrate, nitrite, and [$^{15}N$] nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1982). https://doi.org/10.1016/0003-2697(82)90118-X
  13. Heitmeier, M.R., Scarim, A.L. and Corbett, J.A, Interferon-$\gamma$ increases the sensitivity of islets of langerhans for inducible nitric oxide synthase expression induced by interleukin 1. J. Biol. Chem., 272, 13697-13704 (1997) https://doi.org/10.1074/jbc.272.21.13697
  14. Ignao, L., Endothelium-derived nitric oxide: actions and properties. FASEB J., 3, 31-36 (1989)
  15. Inagaki, R., Taniguchi, T., Sakai, T., Hayashi, N., Ishii, Y. and Muramatsu, I., Anticancer drugs inhibit induction of NO synthase in rat in vivo. Gen. Pharmacol., 32, 185-188 (1999) https://doi.org/10.1016/S0306-3623(98)00179-7
  16. Jaiswal, M., LaRusso, N.F., Burgart, L.J. and Gores, G.J., Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res., 60, 184-190 (2000)
  17. Jenkins, D.C., Charles, I.G., Thomsen, 1.1., Moss, D.W., Homes, I.S., Baylis, S.A, Rhodes, P., Westmore, K., Emson, P.A. and Moncada, S., Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. U.S.A., 92, 4392-4396 (1995) https://doi.org/10.1073/pnas.92.10.4392
  18. Kalivendi, S.V., Kotamraju, S., Zhao, H., Joseph, J. and Kalyanaraman, B., Doxorubicin-induced apoptosis associated with increased transcription of endothelial nitric-oxide synthase. Cancer Res., 276, 47266-47276 (2001)
  19. Lee, H.Y., Lee, J., Kim, E.J., Han, J.W., Lee, H.W., Kang, Y.J. and Chang, K.C., Inhibition of lipopolysaccharide-induced inducible nitric oxide (iNOS) mRNA expression and nitric oxide production by higenamine in murine peritoneal macrophages. Arch. Pharm. Res., 22, 55-59 (1999) https://doi.org/10.1007/BF02976436
  20. O'Neill, L.A.J., Towards an understanding of the signal transduction pathways for interleukin 1. Biochim Biophys Acta, 1266, 31-44 (1995) https://doi.org/10.1016/0167-4889(94)00217-3
  21. Sherman, P.A, Laubach, V.E., Reep, B.R. and Wood, E.R., Purification and eDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry, 32, 11600-11605 (1993) https://doi.org/10.1021/bi00094a017
  22. Siegert, A, Rosenberg, C., Schmitt, W.D., Denkert, C. and Hauptmann, S., Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumor cell invasion. Br. J. Cancer, 86, 1310-1315 (2002) https://doi.org/10.1038/sj.bjc.6600224
  23. Singal, P.K. and Iliskovic, N., Doxorubicin-induced cardiomyopathy. N. Engl. J. Med., 339, 900-905 (1998) https://doi.org/10.1056/NEJM199809243391307
  24. St-Denis, A, Chano, F., Tremblay, P.,St-Pierre,Y. and Descoteaux, A, Protein kinase C-$\alpha$ modulates lipopolysaccharide induced functions in a murine macrophage cell line. J. Biol. Chem., 273, 32787-32792 (1998) https://doi.org/10.1074/jbc.273.49.32787
  25. Thanos, D. and Maniatis, T., NF-$\kappa$B: a lesson in family values. Cell, 80, 529-532 (1995) https://doi.org/10.1016/0092-8674(95)90506-5
  26. Thomsen, L.L., Lawton, F.G., Knowles, R., G., Beesley, J.E., Riveros-Moreno, V and Moncada, S., Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354 (1994)
  27. Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G. and Moncada, S., Nitric oxide syntase activity in human breast cancer. Br. J. Cancer, 72, 41-44 (1995) https://doi.org/10.1038/bjc.1995.274
  28. Xie, K. and Fidler, I.J., Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev., 17, 55-75 (1998) https://doi.org/10.1023/A:1005956721457
  29. Zagozdzon, R., Giermasz, A, Golab, J., Stoklosa, T., Jalili, A. and Jakobisiak, M., The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production. Cancer Lett., 147, 67-75 (1999) https://doi.org/10.1016/S0304-3835(99)00277-3